MORGAN STANLEY - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$1,556,890
+138.9%
111,127
+76.5%
0.00%
Q2 2023$651,564
-50.8%
62,953
-56.1%
0.00%
Q1 2023$1,325,562
+204.1%
143,459
+191.9%
0.00%
Q4 2022$435,953
+15.9%
49,149
+9.2%
0.00%
Q3 2022$376,000
-44.8%
45,010
-46.0%
0.00%
Q2 2022$681,000
+95.1%
83,276
+108.7%
0.00%
Q1 2022$349,000
+63.1%
39,893
+78.3%
0.00%
Q4 2021$214,000
-70.8%
22,374
-48.8%
0.00%
Q3 2021$734,000
-34.8%
43,703
-40.6%
0.00%
Q2 2021$1,125,000
+4587.5%
73,600
+5869.2%
0.00%
Q1 2021$24,000
-92.3%
1,233
-92.8%
0.00%
Q4 2020$310,000
+336.6%
17,178
+366.4%
0.00%
Q3 2020$71,000
-97.0%
3,683
-96.0%
0.00%
-100.0%
Q2 2020$2,377,000
+4070.2%
91,031
+2739.4%
0.00%
Q1 2020$57,000
-93.9%
3,206
-88.6%
0.00%
Q4 2019$935,000
+286.4%
28,009
+175.2%
0.00%
Q3 2019$242,000
+24.7%
10,177
+87.8%
0.00%
Q2 2019$194,000
-78.9%
5,418
-78.3%
0.00%
Q1 2019$920,000
+41.8%
24,923
+65.4%
0.00%
Q4 2018$649,000
-54.0%
15,067
-49.6%
0.00%
Q3 2018$1,412,000
-21.3%
29,890
-17.1%
0.00%
Q2 2018$1,794,000
+25.1%
36,045
+24.9%
0.00%
Q1 2018$1,434,000
+15.4%
28,857
-13.6%
0.00%
Q4 2017$1,243,000
+66.6%
33,412
+41.2%
0.00%
Q3 2017$746,00023,6560.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders